News

Mauna Kea Technologies announces the coverage of its stock by Portzamparc – Groupe BNP Paribas

30 January 2023

Mauna Kea Technologies today announces the coverage of its stock by Portzamparc – Groupe BNP Paribas.

Portzamparc – Groupe BNP Paribas has initiated coverage of the stock with a recommendation to Buy in its report entitled: “The emergence of a new model”.

Latest News

Mauna Kea Technologies Announces Another Milestone Year at Digestive Disease Week® 2025 with 8 Presentations Demonstrating the Clinical Value of Cellvizio® in Key Indications 

Mauna Kea Technologies Announces Another Milestone Year at Digestive Disease Week® 2025 with 8 Presentations Demonstrating the Clinical Value of Cellvizio® in Key Indications 

Mauna Kea Technologies Reports Full Year 2024 Results and Provides a Business Update 

Mauna Kea Technologies Reports Full Year 2024 Results and Provides a Business Update 

Mauna Kea Technologies announces entrance into exclusive negotiations for a licensing agreement for Cellvizio® in an important therapeutic area with a major industry player 

Mauna Kea Technologies announces entrance into exclusive negotiations for a licensing agreement for Cellvizio® in an important therapeutic area with a major industry player